Genetic risk prediction for 10 chronic diseases moves closer to the clinic
As part of a nationwide collaboration, Broad Clinical Labs researchers have optimized 10 polygenic scores for use in clinical research as part of a study on how to implement genetic risk prediction for patients.
Funding
This phase of the eMERGE Network was initiated and funded by the National Human Genome Research Institute.
Paper cited:
Lennon, NJ. et al. Selection, optimization, and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse populations. Nature Medicine. Online February 19, 2024. DOI: 10.1038/s41591-024-02796-z